Related Articles
Decreased expression of protein tyrosine phosphatase non‑receptor type 12 is involved in the proliferation and recurrence of bladder transitional cell carcinoma
The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder
Wild-type p53-induced phosphatase 1 is a prognostic marker and therapeutic target in bladder transitional cell carcinoma
The expression of urokinase-related genes in superficial and invasive transitional cell carcinoma.
Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements